Posted by Michael Wonder on 24 Dec 2024
PHARMAC publishes agenda for February 2025 PTAC meeting
23 December 2024 - PHARMAC has published information on what the PTAC will be considering at its upcoming meeting in February 2025.
The PTAC will consider funding applications for the following technologies:
- Ferric derisomaltose (Monofer), an iron infusion, for an inherited blood vessel disorder
- Rituximab for ANCA vasculitis maintenance treatment
- Nivolumab with ipilimumab for mesothelioma
- Liraglutide for weight loss
- Benralizumab for treating a form of vasculitis
